JP2011521966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011521966A5 JP2011521966A5 JP2011511828A JP2011511828A JP2011521966A5 JP 2011521966 A5 JP2011521966 A5 JP 2011521966A5 JP 2011511828 A JP2011511828 A JP 2011511828A JP 2011511828 A JP2011511828 A JP 2011511828A JP 2011521966 A5 JP2011521966 A5 JP 2011521966A5
- Authority
- JP
- Japan
- Prior art keywords
- mab
- seq
- humanized
- sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5718308P | 2008-05-29 | 2008-05-29 | |
| US61/057,183 | 2008-05-29 | ||
| US17056109P | 2009-04-17 | 2009-04-17 | |
| US61/170,561 | 2009-04-17 | ||
| PCT/US2009/045519 WO2009148928A1 (en) | 2008-05-29 | 2009-05-28 | Monoclonal antibodies to basic fibroblast growth factor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015094533A Division JP2016006034A (ja) | 2008-05-29 | 2015-05-06 | 塩基性線維芽細胞成長因子に対するモノクローナル抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011521966A JP2011521966A (ja) | 2011-07-28 |
| JP2011521966A5 true JP2011521966A5 (cg-RX-API-DMAC7.html) | 2012-06-14 |
| JP5972573B2 JP5972573B2 (ja) | 2016-08-17 |
Family
ID=41398450
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011511828A Expired - Fee Related JP5972573B2 (ja) | 2008-05-29 | 2009-05-28 | 塩基性線維芽細胞成長因子に対するモノクローナル抗体 |
| JP2015094533A Pending JP2016006034A (ja) | 2008-05-29 | 2015-05-06 | 塩基性線維芽細胞成長因子に対するモノクローナル抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015094533A Pending JP2016006034A (ja) | 2008-05-29 | 2015-05-06 | 塩基性線維芽細胞成長因子に対するモノクローナル抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8101725B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2288717B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5972573B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101590495B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102046803B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009255305B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0912035A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2725873C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2633297T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2010012616A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009148928A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101590495B1 (ko) | 2008-05-29 | 2016-02-01 | 갤럭시 바이오테크, 엘엘씨 | 염기성 섬유모세포 성장 인자에 대한 모노클로날 항체 |
| WO2013134414A1 (en) * | 2012-03-06 | 2013-09-12 | Galaxy Biotech, Llc | Bispecific antibodies with an fgf2 binding domain |
| JP2016510751A (ja) | 2013-03-06 | 2016-04-11 | ジェネンテック, インコーポレイテッド | 抗がん剤耐性を治療及び予防する方法 |
| US9415118B2 (en) | 2013-03-13 | 2016-08-16 | Novartis Ag | Antibody drug conjugates |
| US9498532B2 (en) * | 2013-03-13 | 2016-11-22 | Novartis Ag | Antibody drug conjugates |
| WO2015191986A1 (en) | 2014-06-13 | 2015-12-17 | Genentech, Inc. | Methods of treating and preventing cancer drug resistance |
| CN104231079A (zh) * | 2014-09-12 | 2014-12-24 | 暨南大学 | 一种靶向bFGF高亲和力受体结合位点的抗体及其应用 |
| PL238516B1 (pl) | 2016-06-13 | 2021-08-30 | Univ Wroclawski | Sposób otrzymywania modyfikowanego polipeptydu |
| IL266769B2 (en) * | 2016-11-22 | 2024-04-01 | Merck Patent Gmbh | Monoclonal antibodies specific for fgfr1 and their preparation |
| TW202229343A (zh) | 2020-08-21 | 2022-08-01 | 美商健臻公司 | Fgfr3抗體及使用方法 |
| CN115869397B (zh) * | 2022-08-31 | 2026-03-20 | 暨南大学 | Fgf-2纳米抗体在制备治疗银屑病药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU6605690A (en) | 1989-10-27 | 1991-05-31 | Du Pont Merck Pharmaceutical Company, The | Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| JPH07503132A (ja) | 1991-12-17 | 1995-04-06 | ジェンファーム インターナショナル,インコーポレイティド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| US5834597A (en) | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| WO2000046380A2 (en) * | 1999-02-08 | 2000-08-10 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
| IL139380A0 (en) * | 2000-10-31 | 2001-11-25 | Prochon Biotech Ltd | Active variants of fibroblast growth factor |
| EP1476120B1 (en) * | 2002-02-21 | 2010-09-29 | Duke University | Treatment methods using anti-cd22 antibodies |
| US7220410B2 (en) | 2003-04-18 | 2007-05-22 | Galaxy Biotech, Llc | Monoclonal antibodies to hepatocyte growth factor |
| US7560244B2 (en) * | 2003-06-04 | 2009-07-14 | Joslin Diabetes Center, Inc. | Method of evaluating a subject for risk or predisposition of reduced renal function over time |
| EA015363B1 (ru) | 2003-07-18 | 2011-06-30 | Эмджен Инк. | Агенты, специфически связывающие фактор роста гепатоцитов, и их применение |
| JP3904578B2 (ja) | 2005-04-08 | 2007-04-11 | シャープ株式会社 | 半導体装置の製造方法 |
| RU2007146986A (ru) * | 2005-06-02 | 2009-06-27 | ГЭЛЭКСИ БАЙОТЕК, ЭлЭлСи (US) | Способы лечения опухолей головного мозга с использованием антител |
| AR059922A1 (es) | 2006-04-01 | 2008-05-07 | Galaxy Biotech Llc | Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos |
| US7649083B2 (en) | 2006-06-02 | 2010-01-19 | Aveo Pharmaceuticals, Inc. | Hepatocyte growth factor (HGF) binding antibody |
| MX2008015138A (es) | 2006-06-02 | 2009-01-28 | Aveo Pharmaceuticals Inc | Proteinas de union al factor de crecimiento de hepatocitos (fch). |
| KR101590495B1 (ko) | 2008-05-29 | 2016-02-01 | 갤럭시 바이오테크, 엘엘씨 | 염기성 섬유모세포 성장 인자에 대한 모노클로날 항체 |
-
2009
- 2009-05-28 KR KR1020107029136A patent/KR101590495B1/ko not_active Expired - Fee Related
- 2009-05-28 ES ES09759089.7T patent/ES2633297T3/es active Active
- 2009-05-28 MX MX2010012616A patent/MX2010012616A/es active IP Right Grant
- 2009-05-28 CA CA2725873A patent/CA2725873C/en not_active Expired - Fee Related
- 2009-05-28 US US12/474,198 patent/US8101725B2/en not_active Expired - Fee Related
- 2009-05-28 EP EP09759089.7A patent/EP2288717B1/en not_active Revoked
- 2009-05-28 CN CN200980119682.5A patent/CN102046803B/zh not_active Expired - Fee Related
- 2009-05-28 WO PCT/US2009/045519 patent/WO2009148928A1/en not_active Ceased
- 2009-05-28 JP JP2011511828A patent/JP5972573B2/ja not_active Expired - Fee Related
- 2009-05-28 BR BRPI0912035A patent/BRPI0912035A2/pt not_active Application Discontinuation
- 2009-05-28 AU AU2009255305A patent/AU2009255305B2/en not_active Ceased
-
2011
- 2011-12-15 US US13/327,624 patent/US20130209482A1/en not_active Abandoned
-
2015
- 2015-05-06 JP JP2015094533A patent/JP2016006034A/ja active Pending